Mohadeseh Latifi, Mahtab Attarha, Mehran Shayganfard, Mohammad Reza Sharbafchi
{"title":"The Effect of Cognitive-Behavioral Counseling on Sexual Function in Women with Breast Cancer: An Interventional Study.","authors":"Mohadeseh Latifi, Mahtab Attarha, Mehran Shayganfard, Mohammad Reza Sharbafchi","doi":"10.31557/APJCP.2025.26.5.1745","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Breast cancer is the most common malignancy in women worldwide. This can expose all aspect of their life including sexual function. The aim of this research was to investigate the effect of cognitive-behavioral counseling on sexual function in women with breast cancer.</p><p><strong>Methods: </strong>This study was an interventional per-test, post-test design with control group. One hundred women with breast cancer referring to Maxa center in Esfahan at the time of data collection were conventionally selected in 2020. They were randomly divided into intervention and control groups (n=50), using permuted blocks. The intervention group receiving cognitive-behavioral counseling in 10 one-hour, sessions twice a week. Data were collected through a demographic questionnaire, the Female Sexual Function Index (FSFI) questionnaire, filled out by patients before and one month after intervention. Data analyzed using independent t-test, paired t-test, and chi-square. Significance level was considered P <0.05.</p><p><strong>Results: </strong>The results showed that cognitive-behavioral counseling group therapy improved total sexual functioning and its subscales. Four weeks after the counseling, there was a significant difference in mean scores of total sexual functions between the two groups (P = 0.001). In the intervention group the mean scores for lubrication and dyspareunia did not show a significant difference in post-test results (P = 0.129, P = 0.89, respectively).</p><p><strong>Conclusion: </strong>Cognitive - behavioral group therapy can be improved total sexual functioning and its subscales in the intervention group one month after the intervention. So, this method can be used besides with medical treatment as a complementary therapy in oncology wards.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"26 5","pages":"1745-1751"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2025.26.5.1745","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Breast cancer is the most common malignancy in women worldwide. This can expose all aspect of their life including sexual function. The aim of this research was to investigate the effect of cognitive-behavioral counseling on sexual function in women with breast cancer.
Methods: This study was an interventional per-test, post-test design with control group. One hundred women with breast cancer referring to Maxa center in Esfahan at the time of data collection were conventionally selected in 2020. They were randomly divided into intervention and control groups (n=50), using permuted blocks. The intervention group receiving cognitive-behavioral counseling in 10 one-hour, sessions twice a week. Data were collected through a demographic questionnaire, the Female Sexual Function Index (FSFI) questionnaire, filled out by patients before and one month after intervention. Data analyzed using independent t-test, paired t-test, and chi-square. Significance level was considered P <0.05.
Results: The results showed that cognitive-behavioral counseling group therapy improved total sexual functioning and its subscales. Four weeks after the counseling, there was a significant difference in mean scores of total sexual functions between the two groups (P = 0.001). In the intervention group the mean scores for lubrication and dyspareunia did not show a significant difference in post-test results (P = 0.129, P = 0.89, respectively).
Conclusion: Cognitive - behavioral group therapy can be improved total sexual functioning and its subscales in the intervention group one month after the intervention. So, this method can be used besides with medical treatment as a complementary therapy in oncology wards.
期刊介绍:
Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.
The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally.
The APJCP publishes original research results under the following categories:
-Epidemiology, detection and screening.
-Cellular research and bio-markers.
-Identification of bio-targets and agents with novel mechanisms of action.
-Optimal clinical use of existing anti-cancer agents, including combination therapies.
-Radiation and surgery.
-Palliative care.
-Patient adherence, quality of life, satisfaction.
-Health economic evaluations.